NRI Worldwide > Back Home Bytes
Prisioners get remission on Republic Day in Delhi
Report dated 27/01/2014 @ 4:43 PM
24 prisoners were released from Tihar Central Jail and 1000 others got remission in their sentences ranging from 15 days to 2 months on the occasion of India's Republic Day.
The remission facility is given every year on Republic Day in view of the good conduct of prisoners under a section of the Criminal Procedure Code.
Tihar Central Jail houses over 12,000 inmates and is known as South Asia's largest prison that is spread over 400 acres.
21 tourists dead as boat capsizes in Andamans
Report dated 27/01/2014 @ 4:41 PM
21 people died after a boat carrying tourists capsized in the Bay of Bengal, near Port Blair in the Andaman and Nicobar Islands. 13 people were rescued.
Apart from the crew, there were 45 people on board the boat called Aqua Marine, that was travelling between Ross Island and North Bay, including tourists from Kanchi Puram district of Tamil Nadu and Mumbai.
Civil administration and defence establishments including the Coast Guard conducted operations to rescue the remaining passengers, but it was suspected some people may have been trapped in the cabin of the boat. The injured are being treated at a hospital.
An ex-gratia amount of Rs.1 lakh has been announced.
Distraught father of murdered techie meets AAP as last resort
Report dated 26/01/2014 @ 7:23 PM
S Jonathan Prasad father of Esther Anuhya the murdered Mumbai techie, who had approached Union home minister Sushil Kumar Shinde and Maharashtra Home Minister RR Patil, to plead for help to identify Esther's killers and received empty assurances, then met Aam Aadmi Party leader Yogendra Yadav.
Mr. Yadav talked to his party men in Mumbai to take up the case.
Four auto drivers suspected of killing the 23-year-old Esther were detained by Mumbai police who denied they had not cooperated earlier.
Prasad said he would wait and see the results of their new found concern for his dead daughter whose body was found decomposed and burnt in a swamp on the outskirts of Mumbai.
CM Kejriwal invites rickshaw-puller to inaugurate Delhi hospital
Report dated 26/01/2014 @ 7:18 PM
Vijay Baba, 60, a 50-year resident of Delhi could not believe his ears when CM Kejriwal's office informed him that he is invited to cut the ribbon, to inaugurate the New Delhi Municipal Council's upgraded Palika Maternity Hospital, calling it a big honour.
CM Kejriwal had recommended Baba's name when the NDMC invited him to inaugurate the new facility.
The inauguration stone bears Baba's name on the top followed by MP Ajay Maken and CM Kejriwal. Baba a native of Bihar, has been campaigning for the Aam Aadmi Party for the last three years.
‘Cancer drug too expensive for Indians' : Bayer’s derogatory statement
Report dated 26/01/2014 @ 7:16 PM
Speaking at a pharmaceutical forum, Bayer's chief executive Marijn Dekkers said that the giant German firm only developed its cancer drug Nexavar for people who could afford it, not 'for Indians' as the price is too costly and it was developed for western patients who can afford it.
Bayer responded saying the statements attributed to Dekkers were accurate, and forwarded written comments made later by the German chief executive seeking to explain his remarks, in which Dekkers said his words had been a 'quick response' at the forum. He added that in fact Bayer wants "all people to share the fruits of medical progress regardless of their origins or income.
Dekkers also wrote in his comments that he had been particularly frustrated by the Indian controller general of patents' decision to authorise a local drug maker to produce a generic copy of Nexavar, which marked the first time a 'compulsory' licence of a patented drug was awarded in India, referring to the Indian government giving local Natco Pharma a licence to produce a copy of Nexavar, that is used to treat liver and kidney cancer, at a 97% discount on the original selling price of the Bayer product in India.
Medicins San Frontieres (MSF) slammed Dekkers remarks calling it everything that is wrong with the multinational pharmaceutical industry.